DRUG

recombinant thrombomodulin

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for recombinant thrombomodulin

Epilepsy 2

Mediator Outcome Score Tier Lit. status Trial
HMGB1 epilepsy 0.248 Mid novel signal none
HMGB1 drug-resistant epilepsy 0.208 Mid novel signal none

Clinical trials

5 registered trials for recombinant thrombomodulin

Source: ClinicalTrials.gov